Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: A phase i clinical trial

Rosalind Rowland, Ansar A. Pathan, Iman Satti, Ian D. Poulton, Magali M.L. Matsumiya, Megan Whittaker, Angela M. Minassian, Geraldine A. O'Hara, Matthew Hamill, Janet T. Scott, Stephanie A. Harris, Hazel C. Poyntz, Cynthia Bateman, Joel Meyer, Nicola Williams, Sarah C. Gilbert, Alison M. Lawrie, Adrian V.S. Hill, Helen McShane

Research output: Contribution to journal › Article › peer-review

18 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and immunogenicity of an FP9-vectored candidate tuberculosis vaccine (FP85A), alone and with candidate vaccine MVA85A in BCG-vaccinated healthy adults: A phase i clinical trial'. Together they form a unique fingerprint.

Medicine & Life Sciences